The global Autism Diagnostic market was valued at US$ 27900 million in 2023 and is anticipated to reach US$ 47280 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.

Autism Diagnostic Market

Autism or autism spectrum disorder (ASD) is a mental disability characterized by challenges with social skills including impaired social behavior, speech and communication.Autism or ASD is the prevailing disabilities. Thus, the early identification, assessment, and diagnosis is the first step toward autism treatment.Autism Diagnostics Market Segmented By type that is Autistic Disorder, Asperger Syndrome and Childhood Disintegrative Disorder.

North American market for Autism Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Autism Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Autism Diagnostic in Autistic Disorder is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Autism Diagnostic include Pfizer, Inc., Novartis AG, Allergan, Merck&Co Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson&Johnson Services, Inc. and Bristol–Myer Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Autism Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autism Diagnostic.

Report Scope

The Autism Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autism Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autism Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Autism Diagnostic Market Report

Report Metric	Details
Report Name	Autism Diagnostic Market
Accounted market size in 2023	US$ 27900 million
Forecasted market size in 2030	US$ 47280 million
CAGR	8.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Communication and Behavioral Therapy Occupational Therapies Hyperbaric Oxygen Therapy Chelation Therapy Oxytocin Therapy Drug Therapies Others
Segment by Application	Autistic Disorder Asperger Syndrome Childhood Disintegrative Disorder Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Inc., Novartis AG, Allergan, Merck&Co Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson&Johnson Services, Inc., Bristol–Myer Squibb, Otsuka Holdings Co., Ltd., Actavis, Inc., Curemark LLC., Mylan Pharmaceuticals, Asuragen Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autism Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Autism Diagnostic Market growing?

Ans: The Autism Diagnostic Market witnessing a CAGR of 8.3% during the forecast period 2024-2030.

What is the Autism Diagnostic Market size in 2030?

Ans: The Autism Diagnostic Market size in 2030 will be US$ 47280 million.

Who are the main players in the Autism Diagnostic Market report?

Ans: The main players in the Autism Diagnostic Market are Pfizer, Inc., Novartis AG, Allergan, Merck&Co Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson&Johnson Services, Inc., Bristol–Myer Squibb, Otsuka Holdings Co., Ltd., Actavis, Inc., Curemark LLC., Mylan Pharmaceuticals, Asuragen Inc.

What are the Application segmentation covered in the Autism Diagnostic Market report?

Ans: The Applications covered in the Autism Diagnostic Market report are Autistic Disorder, Asperger Syndrome, Childhood Disintegrative Disorder, Others

What are the Type segmentation covered in the Autism Diagnostic Market report?

Ans: The Types covered in the Autism Diagnostic Market report are Communication and Behavioral Therapy, Occupational Therapies, Hyperbaric Oxygen Therapy, Chelation Therapy, Oxytocin Therapy, Drug Therapies, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Autism Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Communication and Behavioral Therapy

1.2.3 Occupational Therapies

1.2.4 Hyperbaric Oxygen Therapy

1.2.5 Chelation Therapy

1.2.6 Oxytocin Therapy

1.2.7 Drug Therapies

1.2.8 Others

1.3 Market by Application

1.3.1 Global Autism Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Autistic Disorder

1.3.3 Asperger Syndrome

1.3.4 Childhood Disintegrative Disorder

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Autism Diagnostic Market Perspective (2019-2030)

2.2 Autism Diagnostic Growth Trends by Region

2.2.1 Global Autism Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Autism Diagnostic Historic Market Size by Region (2019-2024)

2.2.3 Autism Diagnostic Forecasted Market Size by Region (2025-2030)

2.3 Autism Diagnostic Market Dynamics

2.3.1 Autism Diagnostic Industry Trends

2.3.2 Autism Diagnostic Market Drivers

2.3.3 Autism Diagnostic Market Challenges

2.3.4 Autism Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Autism Diagnostic Players by Revenue

3.1.1 Global Top Autism Diagnostic Players by Revenue (2019-2024)

3.1.2 Global Autism Diagnostic Revenue Market Share by Players (2019-2024)

3.2 Global Autism Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Autism Diagnostic Revenue

3.4 Global Autism Diagnostic Market Concentration Ratio

3.4.1 Global Autism Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Autism Diagnostic Revenue in 2023

3.5 Autism Diagnostic Key Players Head office and Area Served

3.6 Key Players Autism Diagnostic Product Solution and Service

3.7 Date of Enter into Autism Diagnostic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Autism Diagnostic Breakdown Data by Type

4.1 Global Autism Diagnostic Historic Market Size by Type (2019-2024)

4.2 Global Autism Diagnostic Forecasted Market Size by Type (2025-2030)

5 Autism Diagnostic Breakdown Data by Application

5.1 Global Autism Diagnostic Historic Market Size by Application (2019-2024)

5.2 Global Autism Diagnostic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Autism Diagnostic Market Size (2019-2030)

6.2 North America Autism Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Autism Diagnostic Market Size by Country (2019-2024)

6.4 North America Autism Diagnostic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Autism Diagnostic Market Size (2019-2030)

7.2 Europe Autism Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Autism Diagnostic Market Size by Country (2019-2024)

7.4 Europe Autism Diagnostic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Autism Diagnostic Market Size (2019-2030)

8.2 Asia-Pacific Autism Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Autism Diagnostic Market Size by Region (2019-2024)

8.4 Asia-Pacific Autism Diagnostic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Autism Diagnostic Market Size (2019-2030)

9.2 Latin America Autism Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Autism Diagnostic Market Size by Country (2019-2024)

9.4 Latin America Autism Diagnostic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Autism Diagnostic Market Size (2019-2030)

10.2 Middle East & Africa Autism Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Autism Diagnostic Market Size by Country (2019-2024)

10.4 Middle East & Africa Autism Diagnostic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer, Inc.

11.1.1 Pfizer, Inc. Company Detail

11.1.2 Pfizer, Inc. Business Overview

11.1.3 Pfizer, Inc. Autism Diagnostic Introduction

11.1.4 Pfizer, Inc. Revenue in Autism Diagnostic Business (2019-2024)

11.1.5 Pfizer, Inc. Recent Development

11.2 Novartis AG

11.2.1 Novartis AG Company Detail

11.2.2 Novartis AG Business Overview

11.2.3 Novartis AG Autism Diagnostic Introduction

11.2.4 Novartis AG Revenue in Autism Diagnostic Business (2019-2024)

11.2.5 Novartis AG Recent Development

11.3 Allergan

11.3.1 Allergan Company Detail

11.3.2 Allergan Business Overview

11.3.3 Allergan Autism Diagnostic Introduction

11.3.4 Allergan Revenue in Autism Diagnostic Business (2019-2024)

11.3.5 Allergan Recent Development

11.4 Merck&Co Inc.

11.4.1 Merck&Co Inc. Company Detail

11.4.2 Merck&Co Inc. Business Overview

11.4.3 Merck&Co Inc. Autism Diagnostic Introduction

11.4.4 Merck&Co Inc. Revenue in Autism Diagnostic Business (2019-2024)

11.4.5 Merck&Co Inc. Recent Development

11.5 Eli Lilly and Company

11.5.1 Eli Lilly and Company Company Detail

11.5.2 Eli Lilly and Company Business Overview

11.5.3 Eli Lilly and Company Autism Diagnostic Introduction

11.5.4 Eli Lilly and Company Revenue in Autism Diagnostic Business (2019-2024)

11.5.5 Eli Lilly and Company Recent Development

11.6 F. Hoffmann-La Roche Ltd.

11.6.1 F. Hoffmann-La Roche Ltd. Company Detail

11.6.2 F. Hoffmann-La Roche Ltd. Business Overview

11.6.3 F. Hoffmann-La Roche Ltd. Autism Diagnostic Introduction

11.6.4 F. Hoffmann-La Roche Ltd. Revenue in Autism Diagnostic Business (2019-2024)

11.6.5 F. Hoffmann-La Roche Ltd. Recent Development

11.7 Teva Pharmaceutical Industries Ltd.

11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail

11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.7.3 Teva Pharmaceutical Industries Ltd. Autism Diagnostic Introduction

11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Autism Diagnostic Business (2019-2024)

11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.8 Johnson&Johnson Services, Inc.

11.8.1 Johnson&Johnson Services, Inc. Company Detail

11.8.2 Johnson&Johnson Services, Inc. Business Overview

11.8.3 Johnson&Johnson Services, Inc. Autism Diagnostic Introduction

11.8.4 Johnson&Johnson Services, Inc. Revenue in Autism Diagnostic Business (2019-2024)

11.8.5 Johnson&Johnson Services, Inc. Recent Development

11.9 Bristol–Myer Squibb

11.9.1 Bristol–Myer Squibb Company Detail

11.9.2 Bristol–Myer Squibb Business Overview

11.9.3 Bristol–Myer Squibb Autism Diagnostic Introduction

11.9.4 Bristol–Myer Squibb Revenue in Autism Diagnostic Business (2019-2024)

11.9.5 Bristol–Myer Squibb Recent Development

11.10 Otsuka Holdings Co., Ltd.

11.10.1 Otsuka Holdings Co., Ltd. Company Detail

11.10.2 Otsuka Holdings Co., Ltd. Business Overview

11.10.3 Otsuka Holdings Co., Ltd. Autism Diagnostic Introduction

11.10.4 Otsuka Holdings Co., Ltd. Revenue in Autism Diagnostic Business (2019-2024)

11.10.5 Otsuka Holdings Co., Ltd. Recent Development

11.11 Actavis, Inc.

11.11.1 Actavis, Inc. Company Detail

11.11.2 Actavis, Inc. Business Overview

11.11.3 Actavis, Inc. Autism Diagnostic Introduction

11.11.4 Actavis, Inc. Revenue in Autism Diagnostic Business (2019-2024)

11.11.5 Actavis, Inc. Recent Development

11.12 Curemark LLC.

11.12.1 Curemark LLC. Company Detail

11.12.2 Curemark LLC. Business Overview

11.12.3 Curemark LLC. Autism Diagnostic Introduction

11.12.4 Curemark LLC. Revenue in Autism Diagnostic Business (2019-2024)

11.12.5 Curemark LLC. Recent Development

11.13 Mylan Pharmaceuticals

11.13.1 Mylan Pharmaceuticals Company Detail

11.13.2 Mylan Pharmaceuticals Business Overview

11.13.3 Mylan Pharmaceuticals Autism Diagnostic Introduction

11.13.4 Mylan Pharmaceuticals Revenue in Autism Diagnostic Business (2019-2024)

11.13.5 Mylan Pharmaceuticals Recent Development

11.14 Asuragen Inc.

11.14.1 Asuragen Inc. Company Detail

11.14.2 Asuragen Inc. Business Overview

11.14.3 Asuragen Inc. Autism Diagnostic Introduction

11.14.4 Asuragen Inc. Revenue in Autism Diagnostic Business (2019-2024)

11.14.5 Asuragen Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eli Lilly and Company

F Hoffmann La Roche Ltd

Teva Pharmaceutical Industries Ltd

Johnson & Johnson Services Inc.

Bristol Myer Squibb

Otsuka Holdings Co Ltd

Actavis

Curemark LLC

Mylan Pharmaceuticals

Asuragen

List of Tables

Table 1. Global Autism Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Communication and Behavioral Therapy

Table 3. Key Players of Occupational Therapies

Table 4. Key Players of Hyperbaric Oxygen Therapy

Table 5. Key Players of Chelation Therapy

Table 6. Key Players of Oxytocin Therapy

Table 7. Key Players of Drug Therapies

Table 8. Key Players of Others

Table 9. Global Autism Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Autism Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Autism Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Autism Diagnostic Market Share by Region (2019-2024)

Table 13. Global Autism Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Autism Diagnostic Market Share by Region (2025-2030)

Table 15. Autism Diagnostic Market Trends

Table 16. Autism Diagnostic Market Drivers

Table 17. Autism Diagnostic Market Challenges

Table 18. Autism Diagnostic Market Restraints

Table 19. Global Autism Diagnostic Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Autism Diagnostic Market Share by Players (2019-2024)

Table 21. Global Top Autism Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autism Diagnostic as of 2023)

Table 22. Ranking of Global Top Autism Diagnostic Companies by Revenue (US$ Million) in 2023

Table 23. Global 5 Largest Players Market Share by Autism Diagnostic Revenue (CR5 and HHI) & (2019-2024)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Autism Diagnostic Product Solution and Service

Table 26. Date of Enter into Autism Diagnostic Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Autism Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Autism Diagnostic Revenue Market Share by Type (2019-2024)

Table 30. Global Autism Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Autism Diagnostic Revenue Market Share by Type (2025-2030)

Table 32. Global Autism Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Autism Diagnostic Revenue Market Share by Application (2019-2024)

Table 34. Global Autism Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Autism Diagnostic Revenue Market Share by Application (2025-2030)

Table 36. North America Autism Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Autism Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Autism Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Autism Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Europe Autism Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 41. Europe Autism Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 42. Asia-Pacific Autism Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 43. Asia-Pacific Autism Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 44. Asia-Pacific Autism Diagnostic Market Size by Region (2025-2030) & (US$ Million)

Table 45. Latin America Autism Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Latin America Autism Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 47. Latin America Autism Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 48. Middle East & Africa Autism Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Middle East & Africa Autism Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 50. Middle East & Africa Autism Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 51. Pfizer, Inc. Company Detail

Table 52. Pfizer, Inc. Business Overview

Table 53. Pfizer, Inc. Autism Diagnostic Product

Table 54. Pfizer, Inc. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 55. Pfizer, Inc. Recent Development

Table 56. Novartis AG Company Detail

Table 57. Novartis AG Business Overview

Table 58. Novartis AG Autism Diagnostic Product

Table 59. Novartis AG Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 60. Novartis AG Recent Development

Table 61. Allergan Company Detail

Table 62. Allergan Business Overview

Table 63. Allergan Autism Diagnostic Product

Table 64. Allergan Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 65. Allergan Recent Development

Table 66. Merck&Co Inc. Company Detail

Table 67. Merck&Co Inc. Business Overview

Table 68. Merck&Co Inc. Autism Diagnostic Product

Table 69. Merck&Co Inc. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 70. Merck&Co Inc. Recent Development

Table 71. Eli Lilly and Company Company Detail

Table 72. Eli Lilly and Company Business Overview

Table 73. Eli Lilly and Company Autism Diagnostic Product

Table 74. Eli Lilly and Company Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 75. Eli Lilly and Company Recent Development

Table 76. F. Hoffmann-La Roche Ltd. Company Detail

Table 77. F. Hoffmann-La Roche Ltd. Business Overview

Table 78. F. Hoffmann-La Roche Ltd. Autism Diagnostic Product

Table 79. F. Hoffmann-La Roche Ltd. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 80. F. Hoffmann-La Roche Ltd. Recent Development

Table 81. Teva Pharmaceutical Industries Ltd. Company Detail

Table 82. Teva Pharmaceutical Industries Ltd. Business Overview

Table 83. Teva Pharmaceutical Industries Ltd. Autism Diagnostic Product

Table 84. Teva Pharmaceutical Industries Ltd. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 85. Teva Pharmaceutical Industries Ltd. Recent Development

Table 86. Johnson&Johnson Services, Inc. Company Detail

Table 87. Johnson&Johnson Services, Inc. Business Overview

Table 88. Johnson&Johnson Services, Inc. Autism Diagnostic Product

Table 89. Johnson&Johnson Services, Inc. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 90. Johnson&Johnson Services, Inc. Recent Development

Table 91. Bristol–Myer Squibb Company Detail

Table 92. Bristol–Myer Squibb Business Overview

Table 93. Bristol–Myer Squibb Autism Diagnostic Product

Table 94. Bristol–Myer Squibb Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 95. Bristol–Myer Squibb Recent Development

Table 96. Otsuka Holdings Co., Ltd. Company Detail

Table 97. Otsuka Holdings Co., Ltd. Business Overview

Table 98. Otsuka Holdings Co., Ltd. Autism Diagnostic Product

Table 99. Otsuka Holdings Co., Ltd. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 100. Otsuka Holdings Co., Ltd. Recent Development

Table 101. Actavis, Inc. Company Detail

Table 102. Actavis, Inc. Business Overview

Table 103. Actavis, Inc. Autism Diagnostic Product

Table 104. Actavis, Inc. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 105. Actavis, Inc. Recent Development

Table 106. Curemark LLC. Company Detail

Table 107. Curemark LLC. Business Overview

Table 108. Curemark LLC. Autism Diagnostic Product

Table 109. Curemark LLC. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 110. Curemark LLC. Recent Development

Table 111. Mylan Pharmaceuticals Company Detail

Table 112. Mylan Pharmaceuticals Business Overview

Table 113. Mylan Pharmaceuticals Autism Diagnostic Product

Table 114. Mylan Pharmaceuticals Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 115. Mylan Pharmaceuticals Recent Development

Table 116. Asuragen Inc. Company Detail

Table 117. Asuragen Inc. Business Overview

Table 118. Asuragen Inc. Autism Diagnostic Product

Table 119. Asuragen Inc. Revenue in Autism Diagnostic Business (2019-2024) & (US$ Million)

Table 120. Asuragen Inc. Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Autism Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Autism Diagnostic Market Share by Type: 2023 VS 2030

Figure 3. Communication and Behavioral Therapy Features

Figure 4. Occupational Therapies Features

Figure 5. Hyperbaric Oxygen Therapy Features

Figure 6. Chelation Therapy Features

Figure 7. Oxytocin Therapy Features

Figure 8. Drug Therapies Features

Figure 9. Others Features

Figure 10. Global Autism Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Autism Diagnostic Market Share by Application: 2023 VS 2030

Figure 12. Autistic Disorder Case Studies

Figure 13. Asperger Syndrome Case Studies

Figure 14. Childhood Disintegrative Disorder Case Studies

Figure 15. Others Case Studies

Figure 16. Autism Diagnostic Report Years Considered

Figure 17. Global Autism Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Autism Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Autism Diagnostic Market Share by Region: 2023 VS 2030

Figure 20. Global Autism Diagnostic Market Share by Players in 2023

Figure 21. Global Top Autism Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autism Diagnostic as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Autism Diagnostic Revenue in 2023

Figure 23. North America Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Autism Diagnostic Market Share by Country (2019-2030)

Figure 25. United States Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Autism Diagnostic Market Share by Country (2019-2030)

Figure 29. Germany Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Autism Diagnostic Market Share by Region (2019-2030)

Figure 37. China Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Autism Diagnostic Market Share by Country (2019-2030)

Figure 45. Mexico Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Autism Diagnostic Market Share by Country (2019-2030)

Figure 49. Turkey Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Autism Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Pfizer, Inc. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 52. Novartis AG Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 53. Allergan Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 54. Merck&Co Inc. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 55. Eli Lilly and Company Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 56. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 57. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 58. Johnson&Johnson Services, Inc. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 59. Bristol–Myer Squibb Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 60. Otsuka Holdings Co., Ltd. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 61. Actavis, Inc. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 62. Curemark LLC. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 63. Mylan Pharmaceuticals Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 64. Asuragen Inc. Revenue Growth Rate in Autism Diagnostic Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cerebral Palsy Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36K2790

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Chorea Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22U5801

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Hydrocephalus Shunts - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9139

Wed Mar 27 00:00:00 UTC 2024

Add to Cart

Global Autism Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29P12566

Mon Mar 25 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions